Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Jan 23, 2006 by Edgar Snyder

Eczema Drugs Get Cancer-Risk Warnings

Eczema Ointment

The Food and Drug Administration (FDA) announced two eczema products are getting “black box” warnings, the most severe type of prescription drug warning issued by the FDA. Elidel and Protopic must now display “black box” labels because of potential cancer risks associated with the drugs.

Both prescription drugs are topical treatments for eczema, a condition that causes dry, scaly patches on the skin that can itch and bleed. Eczema, also known as atopic dermatitis, affects 10%-15% of the child-age population, according to the FDA. The warning comes after animal studies suggested a cancer link, and after a dozen reports of skin cancer and lymphoma were seen among patients.

The FDA recommends the use of Elidel and Protopic only after other treatments for eczema have failed. Children and adults with weakened immune systems should not use the drugs.

For more information about dangerous drugs, visit the Dangerous Drugs Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, claims may involve co-counsel.

Source: “FDA Says Two Eczema Products to Carry Cancer-Risk Warnings.” By Jennifer Corbett Dooren. The Wall Street Journal. January 20, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet